Metrics
Publication
50
Open Access
4
UN Sustainable Development Goals
Announcements & Documents
Download File
Education
2012 - 2018
2012 - 2018Doctorate
Marmara University, Institute of Health Sciences, Department of Medical Biology and Genetics, Turkey
2005 - 2015
2005 - 2015Undergraduate
Anadolu University, Faculty Of Busıness Admınıstratıon (Open Educatıon), İşletme Pr. (Açıköğretim), Turkey
2009 - 2012
2009 - 2012Postgraduate
Marmara University, Institute of Health Sciences, Tıbbi Biyoloji Ve Genetik (Yl) (Tezli), Turkey
2003 - 2007
2003 - 2007Undergraduate
Halic University, Faculty Of Arts And Scıences, Department Of Molecular Bıology And Genetıcs, Turkey
Dissertations
2018
2018Doctorate
Mesane kanseri tanısında kullanılmak üzere üriner protein ve ekzozomal mikro RNA belirteci saptanması 
Marmara University, Institute of Health Sciences, Department of Medical Biology and Genetics
2011
2011Postgraduate
Meme kanserinde MİR-140 ve IGFBP-5 ekspresyon düzeylerinin klinopatolojik faktörlerle ilişkisi
Marmara Üniversitesi, Institute of Health Sciences, Tıbbi Biyoloji Ve Genetik (Yl) (Tezli)
Foreign Languages
C2 Mastery
C2 MasteryEnglish
Research Areas
Health Sciences
Natural Sciences
Research Areas Based on Academic Activities
Avesis Research Areas
WoS Research Areas
Scopus Research Areas
Academic Positions
2022 - Continues
2022 - ContinuesAssistant Professor
Marmara University, School of Medicine, Basic Medical Sciences
2015 - 2022
2015 - 2022Research Assistant PhD
Marmara University, School of Medicine, Basic Medical Sciences
Articles
All (20)
SCI-E, SSCI, AHCI (14)
SCI-E, SSCI, AHCI, ESCI (16)
ESCI (2)
Scopus (17)
TRDizin (4)
Other Publications (2)
2025
20251. NOS1AP: a potential subtype-specific dual role as a tumor suppressor and oncogene in breast cancer subtypes.
Polat B., Amuran G., Eyüboğlu İ. P., Uğurlu M. Ü., Kaya H., Akkiprik M.
Molecular biology reports
, vol.53, no.1, pp.7, 2025 (SCI-Expanded, Scopus)
2024
20242. Neoadjuvant Chemotherapy Shortens the cfDNA Telomere Length in Breast Cancer Patients.
Peker Eyüboğlu İ., Koca S., Çelik B., Güllü Amuran G., Uğurlu M. Ü., Alan Ö., et al.
International journal of breast cancer
, vol.2024, pp.6117394, 2024 (ESCI, Scopus)
2024
20243. A simple and cost-effective real-time PCR method using diluted and heat-treated whole blood lysate.
Güllü Amuran G., Polat B., Kahraman A., Akkiprik M.
SCIENTIFIC REPORTS
, vol.14, no.1, pp.27225, 2024 (SCI-Expanded)
2024
20244. Apocynin exhibits an ameliorative effect on endothelial dysfunction/atherosclerosis-related factors in high-fat diet-induced obesity in rats
Bulbul Ayci N., Ertaş B., Keles Kaya R., Kocyigit Sevinc S., Amuran G., Ercan F., et al.
Marmara Medical Journal
, vol.37, no.2, pp.238-247, 2024 (ESCI, Scopus, TRDizin)
2024
20245. Correlation between plasma ccfDNA, mtDNA changes, CTCs, and epithelial-mesenchymal transition in breast cancer patients undergoing NACT
Çelik B., PEKER EYÜBOĞLU İ., Koca S., Ümit Uğurlu M., Alan Ö., GÜLLÜ AMURAN G., et al.
Turkish Journal of Medical Sciences
, vol.54, no.4, pp.652-665, 2024 (SCI-Expanded, Scopus, TRDizin)
2023
20236. Methodological Study on the Evaluation of the Performance of Archived RNA Samples in Terms of Gene Expression Analyze
Güllü Amuran G., Polat B., Peker Eyüboğlu İ., Özmen T., Kaya H., Akkiprik M.
Türkiye Klinikleri Tıp Bilimleri Dergisi
, vol.43, no.1, 2023 (Scopus, TRDizin)
2020
20207. Comment for the "EpCAM-based Flow Cytometric Detection of Circulating Tumor Cells in Gallbladder Carcinoma Cases".
Gullu A.
Asian Pacific journal of cancer prevention : APJCP
, vol.21, pp.2179, 2020 (SCI-Expanded)
2020
20208. Response Assessment With Molecular Characterization of Circulating Tumor Cells and Plasma MicroRNA Profiling in Patients With Locally Advanced Breast Cancer During Neoadjuvant Chemotherapy
Akkiprik M., Koca S., Uğurlu M. Ü., Ekren R., Peker Eyüboğlu İ., Alan Ö., et al.
CLINICAL BREAST CANCER
, vol.20, no.4, pp.332-346, 2020 (SCI-Expanded, Scopus)
2020
20209. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls
Güllü A., Tinay I., Filinte D., Ilgin C., Peker E., Akkiprik M.
INTERNATIONAL UROLOGY AND NEPHROLOGY
, vol.52, no.3, pp.461-468, 2020 (SCI-Expanded, Scopus)
2020
202010. Next-Generation Sequencing Identifies BRCA1 and/or BRCA2 Mutations in Women at High Hereditary Risk for Breast Cancer with Shorter Telomere Length
Peker E., Yenmiş G., Bingöl E., Yüksel Ş., Tokat F., Özbek P., et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
, vol.24, no.1, pp.5-15, 2020 (SCI-Expanded)
2019
201911. Comment on "Bladder Cancer-Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection"
Amuran G.
DISEASE MARKERS
, vol.2019, 2019 (SCI-Expanded, Scopus)
2018
201812. New Insights in Bladder Cancer Diagnosis: Urinary miRNAs and Proteins.
Güllü Amuran G., Peker Eyüboğlu İ., Tinay İ., Akkiprik M.
Medical sciences (Basel, Switzerland)
, vol.6, no.4, 2018 (Peer-Reviewed Journal)
2018
201813. Exploring the role of miRNAs in the diagnosis of MODY3
Baltaci O. F., Colakoglu S., GÜLLÜ AMURAN G., Aydin N., SARGIN M., Karabay Korkmaz A., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.48, no.3, pp.620-632, 2018 (SCI-Expanded, Scopus, TRDizin)
2017
201714. Comparison of telomere length and insulin-like growth factor-binding protein 7 promoter methylation between breast cancer tissues and adjacent normal tissues in Turkish women
Kaya Z., AKKİPRİK M., Karabulut S., Peker İ., GÜLLÜ AMURAN G., Ozmen T., et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS
, vol.31, no.5, 2017 (SCI-Expanded)
2017
201715. Kanserde Genetik Üstü (Epigenetik) Mekanizmalar
AKKİPRİK M., DİRİCAN E., GÜLLÜ AMURAN G., ÖZER S. A.
Türk Nöroşirorji Dergisi
, vol.27, pp.112-121, 2017 (Peer-Reviewed Journal)
2016
201616. Correlation between the DNA methylation and gene expression of IGFBP5 in breast cancer.
KARABULUT S., KAYA Z., GÜLLÜ AMURAN G., Peker İ., ÖZMEN T., GÜLLÜOĞLU M. B., et al.
BREAST DISEASE
, vol.36, no.4, pp.123, 2016 (Scopus)
2015
201517. Identification of Differentially Expressed IGFBP5-Related Genes in Breast Cancer Tumor Tissues Using cDNA Microarray Experiments
Akkiprik M., Peker İ., Ozmen T., Güllü Amuran G., Gulluoglu B. M., Kaya H., et al.
GENES
, vol.6, no.4, pp.1201-1214, 2015 (SCI-Expanded)
2015
201518. Clinical significance of miR-140-5p and miR-193b expression in patients with breast cancer and relationship to IGFBP5
Gullu G., Peker İ., Haholu A., EREN F., Kucukodaci Z., Gulec B., et al.
GENETICS AND MOLECULAR BIOLOGY
, vol.38, no.1, pp.21-29, 2015 (SCI-Expanded)
2014
201419. Detection of PIK3CA Gene Mutations with HRM Analysis and Association with IGFBP-5 Expression Levels in Breast Cancer
Dirican E., Kaya Z., Gullu G., Peker İ., Ozmen T., Gulluoglu B. M., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, vol.15, no.21, pp.9327-9333, 2014 (SCI-Expanded)
2012
201220. Functional roles and clinical values of insulin-like growth factor-binding protein-5 in different types of cancers
Gullu G., Karabulut S., Akkiprik M.
CHINESE JOURNAL OF CANCER
, vol.31, no.6, pp.266-280, 2012 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. Urinary CRK Concentration Analysis for the Prediction of Recurrence in Non Muscle Invasive Bladder
GÜLLÜ AMURAN G., PEKER EYÜBOĞLU İ., AKKİPRİK M., POLAT B., ŞAHİN B., TİNAY İ., et al.
X. Multidisciplinary Cancer Research Congress, Eskişehir, Turkey, 08 May 2025, (Summary Text)
2025
20252. A simple and cost-effective real-time PCR method using diluted and heat-treated whole blood lysate
GÜLLÜ AMURAN G., POLAT B., Kahraman A., AKKİPRİK M.
European Human Genetics Conference 2025, Milan, Italy, 24 May 2025, (Summary Text)
2022
20223. Evaluation of NOS1AP, TWIST1 AND CDH1 expressions according to molecular subtypes in breast cancer
Polat B., Güllü Amuran G., Uğurlu M. Ü., Kaya H., Akkiprik M.
8th International Congress of the Molecular Biology Association of Turkey (MolBiyoKon’22), İstanbul, Turkey, 09 June 2022, (Summary Text)
2022
20224. Evaluation of NOS1AP, TWIST1 AND CDH1 expressions according to molecular subtypes in breast cancer
POLAT B., GÜLLÜ AMURAN G., UĞURLU M. Ü., KAYA H., AKKİPRİK M.
8th International Congress of the Molecular Biology Association of Turkey (MolBiyoKon’22), İstanbul, Turkey, 09 June 2022, (Full Text)
2019
20195. Mesane Kanseri Tanısında Kullanılmak Üzere Üriner Protein ve Ekzozomal Mikro RNA Belirteci Saptanması
Güllü Amuran G., Tinay İ., Ilgın C., Filinte D., Peker İ.
16. Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2019, (Full Text)
2019
20196. Ailesel Meme Kanseri Hastalarında BRCA1ve BRCA2 Genlerinin Yeni Nesil DizilemeYöntemi ile Dizilenmesi ve TelomerUzunluğuyla İlişkisi
Peker İ., Yenmiş G., Bingöl E. N., Yüksel Ş., Tokat F., Özbek Sarıca P., et al.
XVI. TIBBİ BİYOLOJİ veGENETİK KONGRESİ, Muğla, Turkey, 27 - 30 October 2019, (Full Text)
2019
20197. Ailesel Meme Kanseri Hastalarında BRCA1 ve BRCA2 Genlerinin Yeni Nesil Dizileme Yöntemi ile Dizilenmesi ve Telomer Uzunluğuyla İlişkisi
PEKER EYÜBOĞLU İ., YENMİŞ G., BİNGÖL E. N., YÜKSEL KILIÇTURGAY Ş., TOKAT F., ÖZBEK SARICA P., et al.
Tıbbi Biyoloji ve Genetik kongresi, Turkey, 27 - 30 October 2019, (Summary Text)
2019
20198. Urine Exosomal miR-139-5p, -136-3p and -19b1-5p Expressions and Urinary Ape1/Ref1,BLCA4, Crk Concentrations May Differentiate Bladder Cancer Patients From Healthy Controls
Güllü Amuran G., Tinay İ., Filinte D., Ilgın C., Peker İ., Akkiprik M.
17 th Meeting of the IBCN, Arhus, Denmark, 3 - 05 October 2019, (Full Text)
2019
20199. Urine exosomal miR-139-5p, -136-3p and -19b1-5p expressions and urinary Ape1/Ref1, BLCA4, Crk concentrations may differenciate bladder cancer patients from healthy controls
GÜLLÜ AMURAN G., TİNAY İ., PEKER EYÜBOĞLU İ., AKKİPRİK M.
IBCN, Denmark, 3 - 05 October 2019, (Summary Text)
2019
201910. MESANE KANSERİ TANISI İÇİN İDRARDA BELİRTEÇ OLARAK MİRNA VE PROTEİN PANELİ
Güllü Amuran G., Tinay İ., Filinte D., Ilgın C., Peker İ., Akkiprik M.
14. Üroonkoloji Kongresi, Antalya, Turkey, 6 - 10 November 2019, pp.179-181, (Full Text)
2017
201711. Neoadjuvan kemoterapi alan lokal ileri evre meme kanseri hastalarında dolaşımdaki tümör hücresi moleküler analizleri
AKKİPRİK M., UĞURLU M. Ü., YUMUK P. F., ERZİK C., ALAN Ö., GÜLLÜ AMURAN G., et al.
ulusal tıbbi biyoloji ve genetik kongresi, Muğla, Turkey, 26 - 29 October 2017, (Full Text)
2017
201712. Neoadjuvan kemoterapi alan lokal ileri evrememe kanseri hastalarında dolaşımdaki tümörhücresi moleküler analizleri
AKKİPRİK M., YUMUK P. F., UĞURLU M. Ü., KOCA S., ERZİK C., ALAN Ö., et al.
XV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Uluslararası katılımlı, Turkey, 26 - 29 October 2017, pp.109, (Full Text)
2016
201613. Identification of the functional miRNA miRNAs in the pathogenesis of MODY3
baltaci o. f., çolakoğlu ş., GÜLLÜ AMURAN G., KARABAY KORKMAZ A., BERBER E.
European Society of Human Genetics, 21 - 24 May 2016, (Full Text)
2015
201514. Meme Kanserinde IGFBP5 Yüksek Ekspresyonu ile İlişkili Gen Ekspresyon Profili
AKKİPRİK M., Peker İ., ÖZMEN T., GÜLLÜ AMURAN G., GÜLLÜOĞLU M. B., KAYA H., et al.
XIV. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Muğla, Turkey, 27 - 30 October 2015, (Summary Text)
2015
201515. Assosiation of telomere length variation and IGFBP7 promoter methylation with breast cancer
KAYA Z., AKKİPRİK M., KARABULUT S., Peker İ., GÜLLÜ AMURAN G., ÖZMEN T., et al.
3rd Anticancer Agent Development Congress, İzmir, Turkey, 18 - 19 May 2015, (Summary Text)
2015
201516. Association of telomere length variation and IGFBP7 promoter methylation with breast cancer
Kaya Z., Akkiprik M., Karabulut S., Peker İ., Güllü Amuran G., Özmen T., et al.
EACR-Sponsored 3rd Anticancer Agent Development Congress, İzmir, Turkey, 18 - 19 May 2015, (Summary Text)
2014
201417. Meme kanserinde PIK3CA gen mutasyonlarının hrm yöntemiyle belirlenmesi ve IGFBP-5 ekspresyonu düzeyi ile ilişkisi
DİRİCAN E., KAYA Z., GÜLLÜ AMURAN G., PEKER EYÜBOĞLU İ., ÖZMEN T., GÜLLÜOĞLU M. B., et al.
anticancer agents congress, Turkey, 23 April 2014, (Summary Text)
2013
201318. Meme kanserinde miR-140 ve IGFBP-5 ekspresyon düzeyleri arasındaki ilişkinin araştırılması
GÜLLÜ AMURAN G., Peker İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., et al.
XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2013, (Full Text)
2013
201319. Meme kanserinde insülin benzeri büyüme faktörü bağlayan protein-5 geni promotör ve ekzon -1 metilasyonunun gen ekspresyonu üzerine etkisi
KARABULUT S., KAYA Z., GÜLLÜ AMURAN G., ÖZMEN T., ERZİK C., ÖZER S. A., et al.
XIII. Ulusal Tıbbi Bitoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2013, (Full Text)
2013
201320. miR-193b ekspresyon düzeyi ile ERalfa ve IGFBP5 ilişkisinin meme kanserindeki rolü
Peker İ., GÜLLÜ AMURAN G., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., EREN F., et al.
XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2013, (Full Text)
2013
201321. Association of IGFBP-5 exon-I methylation and gene expression inbreast cancer
KARABULUT S., KAYA Z., GÜLLÜ AMURAN G., Peker İ., ÖZMEN T., ERZİK C., et al.
European hHuman Genetics Conference 2013, Paris, France, 8 - 11 June 2013, pp.369-370, (Summary Text)
2013
201322. Association of IGFBP5 and ERalpha with mir193b expression levels inbreast cancer
Peker İ., Güllü Amuran G., Haholu A., Erzik C., Küçükodacı Z., Özer S. A., et al.
European Human Genetics Conference 2013, Paris, France, 8 - 11 June 2013, (Full Text)
2013
201323. mir-140 is a Candidate Regulator of IGFBP5 Expression in BreastCancer
GÜLLÜ AMURAN G., Peker İ., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., ÖZER S. A., et al.
European Human Genetics Conference 2013, Paris, France, 8 - 11 June 2013, pp.529-530, (Full Text)
2012
201224. Meme Kanserinde miR-140 ve IGFBP-5 Ekspresyon Düzeyleri Arasındaki İlişkinin Araştırılması
GÜLLÜ AMURAN G., Peker İ., HAHOLU A., EREN F., KÜÇÜKODACI Z., ERZİK C., et al.
IV. Multidisipliner Kanser Araştırma Kongresi, Bursa, Turkey, 13 - 16 December 2012, (Full Text)
2012
201225. miR-193b EKSPRESYON DÜZEYİ ile ERalfa ve IGFBP5 İLİŞKİSİNİN MEME KANSERİNDEKİ ROLÜ
Peker İ., GÜLLÜ AMURAN G., HAHOLU A., ERZİK C., KÜÇÜKODACI Z., EREN F., et al.
IV. Multidisipliner Kanser Araştırma Kongresi, Bursa, Turkey, 13 - 16 December 2012, (Summary Text)
Books
2025
20251. KANSERİN MOLEKÜLER TEMELLERİ
GÜLLÜ AMURAN G.
in: TIBBI BIYOLOJI VE GENETIĞIN TEMEL ADIMLARI, YENMİŞ GÜVEN, AYDEMİR AYAZ ESRA, Editor, Ankara Nobel Tıp Kitabevleri, Ankara, pp.419-445, 2025
2023
20232. Protein Sentezi ve Modifikasyonları
GÜLLÜ AMURAN G., ÖZER S. A., PEKER EYÜBOĞLU İ.
in: İnsan Moleküler Biyolojisi, Sunguroğlu, Asuma ; Erdem Yurter, Hayat ; Ataç , Belgin ; Aydos, O. Sena, Editor, Hipokrat Yayıncılık, Ankara, pp.85-115, 2023
2022
20223. Kanser Genetiği
GÜLLÜ AMURAN G.
in: Diş Hekimliği Öğrencileri İçin Tıbbi Biyoloji, Pınar Gültepe Jordacevic, Editor, Nobel Tıp Kitabevleri, Konya, pp.183-197, 2022
2022
20224. Tıbbi Biyoloji ve Genetikte Kullanılan Yöntemler
GÜLLÜ AMURAN G.
in: Diş Hekimliği Öğrencileri İçin Tıbbi Biyoloji, Pınar Gültepe Jordacevic, Editor, Nobel Tıp Kitabevleri, Konya, pp.279-284, 2022
2012
20125. Ürolojik Hastalıkların Moleküler Temeli
GÜLLÜ AMURAN G., ÖZER S. A., ERZİK C., AKKİPRİK M.
in: MOLEKÜLER ÜROLOJİ ÜROLOJİK HASTALIKLARIN MOLEKÜLER TEMELİ, Levent TÜRKERİ, Ayşe ÖZER, Fehmi NARTER, Editor, ÜROONKOLOJİ DERNEĞİ, pp.135-147, 2012
Funded Projects
2023 - 2026
2023 - 2026
Circulating tumour microenvironment components as Urothelial Cancer Immunotherapy Response Predictors.
TÜBİTAK International Multi-Cooperation Project , ERA.NET Project
(Project Abstract)
Güllü Amuran G. (Executive), Akkiprik M., Arğa K. Y., Erzik C., Şahin B.
2022 - 2024
2022 - 2024SPİNAL MUSKÜLER ATROFİ (SMA) HASTALIĞINA YÖNELİK TANI VE TARAMA KİTİ GELİŞTİRİLMESİ
Research Project of the Presidency of Turkey Health Institutes (TÜSEB)
Ünver O., Akkiprik M., Türkdoğan D., Güllü Amuran G. (Executive)
2022 - 2024
2022 - 2024SPİNAL MUSKÜLER ATROFİ (SMA) HASTALIĞINA YÖNELİK TANI VE TARAMA KİTİ GELİŞTİRİLMESİ
Research Project of the Presidency of Turkey Health Institutes (TÜSEB)
(Project Abstract)
Güllü Amuran G. (Executive), Türkdoğan D., Akkiprik M., Ünver O.
2016 - 2017
2016 - 2017
Mesane kanseri tanısında kullanılmak üzere üriner protein ve ekzozomal mikro RNA belirteci saptanması
Project Supported by Higher Education Institutions , BAP PhD
Akkiprik M. (Executive), Güllü Amuran G.
2013 - 2016
2013 - 2016Maturity onset Diabetes of the Young 3 MODY3 ün moleküler patolojisinde ve ayırıcı klinik tanısında miRNA ların fonksiyonel rolününün araştırılması
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
Berber E.(Executive)
2011 - 2013
2011 - 2013Meme Kanserinde IGFBP 5 ile etkileşen proteinlerin tanımlanması
TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects
Akkiprik M.(Executive)
Memberships and Roles in Scientific Organizations
2009 - Continues
2009 - ContinuesTıbbi Biyoloji ve Genetik Derneği
Member
Peer Reviews in Scientific Publications
December 2020
December 2020JOURNAL OF CLINICAL LABORATORY ANALYSIS
SCI Journal
August 2020
August 2020BIOMARKERS
SCI Journal
February 2020
February 2020MEDICAL SCIENCE MONITOR
SCI Journal
February 2020
February 2020MEDICAL SCIENCE MONITOR
SCI Journal
July 2019
July 2019Medical Science Monitor
SCI Journal
Scientific Project Refereeing
February 2022
February 2022Research Project of the Presidency of Turkey Health Institutes (TÜSEB)
Dokuz Eylul University, Turkey
February 2022
February 2022Research Project of the Presidency of Turkey Health Institutes (TÜSEB)
Istanbul University, Turkey
Awards
April 2015
April 2015Marmara Tıbbi Hizmetleri Geliştirme ve Yardım Derneği Bilimsel Araştırma Ödülü Yarışması Üçüncülük Ödülü
Marmara Tıbbi Hizmetleri Geliştirme Ve Yardım Derneği
Congress and Symposium Activities
01 December 2012 - 01 December 2012
01 December 2012 - 01 December 2012Araştırma Tekniklerine Giriş ve Biyoistatistik Kursu
Working Group
İstanbul-Turkey
01 September 2012 - 01 September 2012
01 September 2012 - 01 September 2012Klinik Araştırma Metodları Kursu
Working Group
İstanbul-Turkey
01 May 2005 - 01 May 2005
01 May 2005 - 01 May 2005